Growth Metrics

Edwards Lifesciences (EW) Work In Process (2016 - 2025)

Edwards Lifesciences has reported Work In Process over the past 12 years, most recently at $252.9 million for Q4 2025.

  • Quarterly results put Work In Process at $252.9 million for Q4 2025, up 7.07% from a year ago — trailing twelve months through Dec 2025 was $252.9 million (up 7.07% YoY), and the annual figure for FY2025 was $252.9 million, up 7.07%.
  • Work In Process for Q4 2025 was $252.9 million at Edwards Lifesciences, down from $275.9 million in the prior quarter.
  • Over the last five years, Work In Process for EW hit a ceiling of $275.9 million in Q3 2025 and a floor of $195.8 million in Q4 2023.
  • Median Work In Process over the past 3 years was $252.9 million (2025), compared with a mean of $247.0 million.
  • Biggest five-year swings in Work In Process: rose 20.63% in 2024 and later grew 0.62% in 2025.
  • Edwards Lifesciences' Work In Process stood at $195.8 million in 2023, then rose by 20.63% to $236.2 million in 2024, then rose by 7.07% to $252.9 million in 2025.
  • The last three reported values for Work In Process were $252.9 million (Q4 2025), $275.9 million (Q3 2025), and $261.4 million (Q2 2025) per Business Quant data.